These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1516271)

  • 1. Potassium channel activation improves blood flow pattern of conscious rats in cutaneous microcirculation.
    Hertel RF
    Clin Exp Pharmacol Physiol; 1992 Apr; 19(4):243-8. PubMed ID: 1516271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.
    Sassen LM; Duncker DJ; Gho BC; Diekmann HW; Verdouw PD
    Br J Pharmacol; 1990 Nov; 101(3):605-14. PubMed ID: 2076480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential small arteriolar vasodilatation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive rats.
    Struijker Boudier HA; Messing MW; van Essen H
    Eur J Pharmacol; 1992 Jul; 218(1):191-3. PubMed ID: 1397031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel K+ channel activator, EMD 52962, in electrophysiological and pharmacological experiments.
    De Peyer JE; Lues I; Gericke R; Häusler G
    Pflugers Arch; 1989; 414 Suppl 1():S191. PubMed ID: 2780258
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an ATP sensitive potassium channel opener, levcromakalim, on coronary arterial microvessels in the beating canine heart.
    Sato K; Kanatsuka H; Sekiguchi N; Akai K; Wang Y; Sugimura A; Kumagai T; Komaru T; Shirato K
    Cardiovasc Res; 1994 Dec; 28(12):1780-6. PubMed ID: 7867030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of ATP-sensitive potassium channels in beta 2-adrenoceptor agonist-induced vasodilatation on rat diaphragmatic microcirculation.
    Chang HY
    Br J Pharmacol; 1997 Jul; 121(5):1024-30. PubMed ID: 9222563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized rats.
    Smits GJ; Perrone MH; Cox BF
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):49-56. PubMed ID: 9007670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic profile of SKP-450, a new potassium-channel activator.
    Lee BH; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):85-94. PubMed ID: 9456282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bimakalim (EMD 52692), an opener of ATP sensitive potassium channels, on infarct size, coronary blood flow, regional wall function, and oxygen consumption in swine.
    Rohmann S; Weygandt H; Schelling P; Soei LK; Becker KH; Verdouw PD; Lues I; Häusler G
    Cardiovasc Res; 1994 Jun; 28(6):858-63. PubMed ID: 7923292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of ATP-sensitive potassium channels lowers threshold for ischemic preconditioning in dogs.
    Yao Z; Gross GJ
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1888-94. PubMed ID: 7977819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
    Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia.
    Trezise DJ; Drew GM; Roach AG; Watts IS; Weston AH
    Eur J Pharmacol; 1993 Nov; 250(1):109-16. PubMed ID: 8119308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats.
    Yamashita T; Masuda Y; Kawamura N; Fujikura N; Tanaka S
    Jpn J Pharmacol; 1995 Jun; 68(2):145-52. PubMed ID: 7563971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of the novel potassium channel opener UR-8225.
    Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic cyclosporine. A treatment on the skin microcirculation of conscious rats.
    Hertel RF; Bossaller C
    Z Kardiol; 1989; 78 Suppl 6():92-4. PubMed ID: 2618133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310.
    Shin HS; Seo HW; Yoo SE; Lee BH
    Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.